Efficacy of detogen-B, a medicinal plant formulation in cancer diseases

International Conference and Exhibition on Marine Drugs and Natural Products

July 25-27, 2016 Melbourne, Australia

Ekenna Elikee

Ekenna Natures Ltd., Nigeria

Scientific Tracks Abstracts: J Pharmacogn Nat Prod

Abstract :

Recent global statistics shows that cancers claim more than 8 million lives, while kidney diseases register up to one million cases annually, with most cases defying even the conventional orthodox medications. Hence, there is always need to explore alternative approaches to effective cures. Some cases of cancer and kidney failure that have been established in teaching hospitals or licensed diagnostic laboratories were subjected to our extemporaneous herbal preparations from already researched plants with established phytochemical properties. Histories of patients� diets were taken, and the toxicological properties of the food additives noted as possible risk factors in the disease conditions. Following our treatment protocol, patients with cancers of the liver, cervix, bone, lungs including cirrhosis, fatty liver and severe kidney diseases have recovered and are now stable. Laboratory evidences from CT scans, X-ray images, and Bence Jones protein clearance tests were obtained. The first-line drug in these treatments is Detogen-B. This herbal formulation has passed through sub-acute and sub-chronic toxicity tests conducted by the Nigeria Natural Medicine Development Agency (NNMDA), under the auspices of the Federal Ministry of Science and Technology, in conjunction with the Lagos University Teaching Hospital (LUTH). Animal organ tests showed a graphical increase in the mean weights of the liver, pancreas and lungs showing its activity in the regeneration of tissues. Reduction of LDL and triglycerides levels showed its detoxification and cardiovascular effects. The Haematological profile shows increase in the levels of WBC, MCH, MCHC and platelets without changes in the levels of RBC and procalcitonin. All these are indications of the effects of Detogen-B in the treatment of lesions, cancers, haemangioma and very degenerative disease conditions with immunostimulatory effects.

Biography :

Ekenna Elikee is a graduate of the University of Nigeria Nsukka. He is the MD of Ekenna Natures Limited and has devoted more than 10 years after graduation in understanding the science of phytochemistry and using such knowledge in cure of so many intractable diseases including cancers, kidney/liver diseases and cardiovascular disorders.

Email: ekennanatures@yahoo.com